PURPOSE: Radiosurgery has been successfully used in selected cases to avoid repeat whole-brain irradiation (WBI) in patients with multiple brain metastases of most solid tumor histological findings. Few data are available for the use of radiosurgery for small-cell lung cancer (SCLC). METHODS AND MATERIALS: Between November 1999 and June 2009, 51 patients with SCLC and previous WBI and new brain metastases were treated with GammaKnife stereotactic radiosurgery (GKSRS). A median dose of 18 Gy (range, 10-24 Gy) was prescribed to the margin of each metastasis. Patients were followed with serial imaging. Patient electronic records were reviewed to determine disease-related factors and clinical outcomes after GKSRS. Local and distant brain failure rates, overall survival, and likelihood of neurologic death were determined based on imaging results. The Kaplan-Meier method was used to determine survival and local and distant brain control. Cox proportional hazard regression was performed to determine strength of association between disease-related factors and survival. RESULTS: Median survival time for the entire cohort was 5.9 months. Local control rates at 1 and 2 years were 57% and 34%, respectively. Distant brain failure rates at 1 and 2 years were 58% and 75%, respectively. Fifty-three percent of patients ultimately died of neurologic death. On multivariate analysis, patients with stable (hazard ratio [HR] = 2.89) or progressive (HR = 6.98) extracranial disease (ECD) had worse overall survival than patients without evidence of ECD (p = 0.00002). Concurrent chemotherapy improved local control (HR = 89; p = 0.006). CONCLUSIONS: GKSRS represents a feasible salvage option in patients with SCLC and brain metastases for whom previous WBI has failed. The status of patients' ECD is a dominant factor predictive of overall survival. Local control may be inferior to that seen with other cancer histological results, although the use of concurrent chemotherapy may help to improve this.
PURPOSE: Radiosurgery has been successfully used in selected cases to avoid repeat whole-brain irradiation (WBI) in patients with multiple brain metastases of most solid tumor histological findings. Few data are available for the use of radiosurgery for small-cell lung cancer (SCLC). METHODS AND MATERIALS: Between November 1999 and June 2009, 51 patients with SCLC and previous WBI and new brain metastases were treated with GammaKnife stereotactic radiosurgery (GKSRS). A median dose of 18 Gy (range, 10-24 Gy) was prescribed to the margin of each metastasis. Patients were followed with serial imaging. Patient electronic records were reviewed to determine disease-related factors and clinical outcomes after GKSRS. Local and distant brain failure rates, overall survival, and likelihood of neurologic death were determined based on imaging results. The Kaplan-Meier method was used to determine survival and local and distant brain control. Cox proportional hazard regression was performed to determine strength of association between disease-related factors and survival. RESULTS: Median survival time for the entire cohort was 5.9 months. Local control rates at 1 and 2 years were 57% and 34%, respectively. Distant brain failure rates at 1 and 2 years were 58% and 75%, respectively. Fifty-three percent of patients ultimately died of neurologic death. On multivariate analysis, patients with stable (hazard ratio [HR] = 2.89) or progressive (HR = 6.98) extracranial disease (ECD) had worse overall survival than patients without evidence of ECD (p = 0.00002). Concurrent chemotherapy improved local control (HR = 89; p = 0.006). CONCLUSIONS: GKSRS represents a feasible salvage option in patients with SCLC and brain metastases for whom previous WBI has failed. The status of patients' ECD is a dominant factor predictive of overall survival. Local control may be inferior to that seen with other cancer histological results, although the use of concurrent chemotherapy may help to improve this.
Authors: A Aupérin; R Arriagada; J P Pignon; C Le Péchoux; A Gregor; R J Stephens; P E Kristjansen; B E Johnson; H Ueoka; H Wagner; J Aisner Journal: N Engl J Med Date: 1999-08-12 Impact factor: 91.245
Authors: E Shaw; C Scott; L Souhami; R Dinapoli; R Kline; J Loeffler; N Farnan Journal: Int J Radiat Oncol Biol Phys Date: 2000-05-01 Impact factor: 7.038
Authors: Samuel T Chao; Gene H Barnett; Michael A Vogelbaum; Lilyana Angelov; Robert J Weil; Gennady Neyman; Alwyn M Reuther; John H Suh Journal: Cancer Date: 2008-10-15 Impact factor: 6.860
Authors: Eric L Chang; Jeffrey S Wefel; Kenneth R Hess; Pamela K Allen; Frederick F Lang; David G Kornguth; Rebecca B Arbuckle; J Michael Swint; Almon S Shiu; Moshe H Maor; Christina A Meyers Journal: Lancet Oncol Date: 2009-10-02 Impact factor: 41.316
Authors: Paul J Black; Brandi R Page; John T Lucas; Ryan T Hughes; Adrian W Laxton; Stephen B Tatter; Michael T Munley; Michael D Chan Journal: J Radiosurg SBRT Date: 2015
Authors: Diandra N Ayala-Peacock; Albert Attia; Steve E Braunstein; Manmeet S Ahluwalia; Jaroslaw Hepel; Caroline Chung; Joseph Contessa; Emory McTyre; Ann M Peiffer; John T Lucas; Scott Isom; Nicholas M Pajewski; Rupesh Kotecha; Mark J Stavas; Brandi R Page; Lawrence Kleinberg; Colette Shen; Robert B Taylor; Nasarachi E Onyeuku; Andrew T Hyde; Daniel Gorovets; Samuel T Chao; Christopher Corso; Jimmy Ruiz; Kounosuke Watabe; Stephen B Tatter; Gelareh Zadeh; Veronica L S Chiang; John B Fiveash; Michael D Chan Journal: J Neurooncol Date: 2017-08-21 Impact factor: 4.130
Authors: Rachel F Shenker; Emory R McTyre; Glen B Taksler; Ralph B D'Agostino; Christina K Cramer; Jimmy Ruiz; Natalie K Alphonse-Sullivan; Michael Farris; Kounosuke Watabe; Fei Xing; Adrian W Laxton; Stephen B Tatter; Michael D Chan Journal: Clin Neurol Neurosurg Date: 2018-11-13 Impact factor: 1.876
Authors: Michael C LeCompte; Emory McTyre; Adrianna Henson; Michael Farris; Catherine Okoukoni; Christina K Cramer; Pierre Triozzi; Jimmy Ruiz; Kounosuke Watabe; Hui-Wen Lo; Michael T Munley; Adrian W Laxton; Stephen B Tatter; Xiaobo Zhou; Michael Chan Journal: Cureus Date: 2017-12-11
Authors: Christopher P Cifarelli; John A Vargo; Wei Fang; Roman Liscak; Khumar Guseynova; Ronald E Warnick; Cheng-Chia Lee; Huai-Che Yang; Hamid Borghei-Razavi; Tonmoy Maiti; Zaid A Siddiqui; Justin C Yuan; Inga S Grills; David Mathieu; Charles J Touchette; Diogo Cordeiro; Veronica Chiang; Judith Hess; Christopher J Tien; Andrew Faramand; Hideyuki Kano; Gene H Barnett; Jason P Sheehan; L Dade Lunsford Journal: Neurosurgery Date: 2020-09-15 Impact factor: 4.654
Authors: John T Lucas; Hentry G Colmer; Lance White; Nora Fitzgerald; Scott Isom; John D Bourland; Adrian W Laxton; Stephen B Tatter; Michael D Chan Journal: Int J Radiat Oncol Biol Phys Date: 2015-04-23 Impact factor: 7.038
Authors: J Griff Kuremsky; James J Urbanic; W Jeff Petty; James F Lovato; J Daniel Bourland; Stephen B Tatter; Thomas L Ellis; Kevin P McMullen; Edward G Shaw; Michael D Chan Journal: Neurosurgery Date: 2013-10 Impact factor: 4.654